| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 4, Issue 2 57-65, Copyright © 1993 by American Association of Cancer Research
ARTICLES |
D Reisman, NB Elkind, B Roy, J Beamon and V Rotter
Department of Biological Sciences, University of South Carolina, Columbia 29208.
c-Myc and wild-type p53 have been shown to play important roles in the regulation of cellular proliferation and oncogenic transformation. We have previously shown that the p53 promoter contains a conserved consensus recognition sequence for the basic-helix-loop-helix-containing proteins, identical to the specific binding site for c-Myc/Max heterodimers. Here, we demonstrate that this element, which is required for full promoter activity, is bound by in vitro translated c-Myc/Max heterodimers. Furthermore, we found that in cotransfection assays, c-Myc trans-activates the p53 promoter as well as a hybrid herpes simplex virus-thymidine kinase promoter containing multiple copies of a synthetic p53-derived c-Myc binding site. The p53 promoter deleted of the basic-helix-loop-helix consensus recognition sequence is not trans-activated by c-Myc, thus suggesting that c-Myc trans-activates the p53 promoter through the basic-helix-loop-helix recognition motif. These findings raise the possibility that the p53 gene may be a potential target for trans-activation by c-Myc in vivo.
This article has been cited by other articles:
![]() |
D. Yu, M. Carroll, and A. Thomas-Tikhonenko p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitors Blood, June 1, 2007; 109(11): 4936 - 4943. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dose, I. Khan, Z. Guo, D. Kovalovsky, A. Krueger, H. von Boehmer, K. Khazaie, and F. Gounari c-Myc mediates pre-TCR-induced proliferation but not developmental progression Blood, October 15, 2006; 108(8): 2669 - 2677. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ozawa, M. Shichiri, N. Fukai, T. Yoshimoto, and Y. Hirata Regulation of Adrenomedullin Gene Transcription and Degradation by the c-myc Gene Endocrinology, September 1, 2004; 145(9): 4244 - 4250. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xiao, P. Jethanandani, B. L. Ziober, and R. H. Kramer Regulation of {alpha}7 Integrin Expression during Muscle Differentiation J. Biol. Chem., December 12, 2003; 278(50): 49780 - 49788. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Harris, E. White, E. S. Phillips, and K. A. Lillycrop The Expression of the Developmentally Regulated Proto-oncogene Pax-3 Is Modulated by N-Myc J. Biol. Chem., September 13, 2002; 277(38): 34815 - 34825. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Yu, M. He, N. H. Lee, and E. T. Liu Identification of Myc-mediated Death Response Pathways by Microarray Analysis J. Biol. Chem., April 5, 2002; 277(15): 13059 - 13066. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Sheen and R. B. Dickson Overexpression of c-Myc Alters G1/S Arrest following Ionizing Radiation Mol. Cell. Biol., March 15, 2002; 22(6): 1819 - 1833. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Adachi, A. J. Obaya, Z. Han, N. Ramos-Desimone, J. H. Wyche, and J. M. Sedivy c-Myc Is Necessary for DNA Damage-Induced Apoptosis in the G2 Phase of the Cell Cycle Mol. Cell. Biol., August 1, 2001; 21(15): 4929 - 4937. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Shiotani, Y. Nonaka, T. Hashimoto, K. Kihara, K. Kanazawa, G.-i. Danno, and H. Ashida DNA-damaging carcinogen 3-amino-1,4-dimethyl-5H-pyrido [4,3-b]indole (Trp-P-1) induces apoptosis via caspase-9 in primary cultured rat hepatocytes Carcinogenesis, May 1, 2001; 22(5): 693 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. SHICHIRI and Y. HIRATA Antiangiogenesis signals by endostatin FASEB J, April 1, 2001; 15(6): 1044 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Gartel, X. Ye, E. Goufman, P. Shianov, N. Hay, F. Najmabadi, and A. L. Tyner Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3 PNAS, March 22, 2001; (2001) 81074898. [Abstract] [Full Text] |
||||
![]() |
I. P. Pogribny, M. Pogribna, J. K. Christman, and S. J. James Single-Site Methylation within the p53 Promoter Region Reduces Gene Expression in a Reporter Gene Construct: Possible in Vivo Relevance during Tumorigenesis Cancer Res., February 1, 2000; 60(3): 588 - 594. [Abstract] [Full Text] |
||||
![]() |
M. Oren Regulation of the p53 Tumor Suppressor Protein J. Biol. Chem., December 17, 1999; 274(51): 36031 - 36034. [Full Text] [PDF] |
||||
![]() |
T. K. Hale and A. W. Braithwaite The Adenovirus Oncoprotein E1a Stimulates Binding of Transcription Factor ETF to Transcriptionally Activate the p53 Gene J. Biol. Chem., August 20, 1999; 274(34): 23777 - 23786. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Planque, N. Turque, K. Opdecamp, M. Bailly, P. Martin, and S. Saule Expression of the Microphthalmia-associated Basic Helix-Loop-Helix Leucine Zipper Transcription Factor Miin Avian Neuroretina Cells Induces aPigmented Phenotype Cell Growth Differ., July 1, 1999; 10(7): 525 - 536. [Abstract] [Full Text] |
||||
![]() |
I. Ben-Porath, O. Yanuka, and N. Benvenisty The Tmp Gene, Encoding a Membrane Protein, Is a c-Myc Target with a Tumorigenic Activity Mol. Cell. Biol., May 1, 1999; 19(5): 3529 - 3539. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Macdonald and M. R. Bennett cdc25A Is Necessary but Not Sufficient for Optimal c-myc–Induced Apoptosis and Cell Proliferation of Vascular Smooth Muscle Cells Circ. Res., April 16, 1999; 84(7): 820 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Dang c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism Mol. Cell. Biol., January 1, 1999; 19(1): 1 - 11. [Full Text] [PDF] |
||||
![]() |
A. Bush, M. Mateyak, K. Dugan, A. Obaya, S. Adachi, J. Sedivy, and M. Cole c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets Genes & Dev., December 15, 1998; 12(24): 3797 - 3802. [Abstract] [Full Text] |
||||
![]() |
Q. Xiao, G. Claassen, J. Shi, S. Adachi, J. Sedivy, and S. R. Hann Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis Genes & Dev., December 15, 1998; 12(24): 3803 - 3808. [Abstract] [Full Text] |
||||
![]() |
L. Facchini and L. Z. Penn The molecular role of Myc in growth and transformation: recent discoveries lead to new insights FASEB J, June 1, 1998; 12(9): 633 - 651. [Abstract] [Full Text] |
||||
![]() |
M. Wu, R. E. Bellas, J. Shen, and G. E. Sonenshein Roles of the Tumor Suppressor p53 and the Cyclin-dependent Kinase Inhibitor p21WAF1/CIP1 in Receptor-mediated Apoptosis of WEHI 231 B Lymphoma Cells J. Exp. Med., May 18, 1998; 187(10): 1671 - 1679. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shichiri, S. Adachi, J. M. Sedivy, F. Marumo, and Y. Hirata Biphasic Regulation of the Preproendothelin-1 Gene by c-myc Endocrinology, November 1, 1997; 138(11): 4584 - 4590. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Eden, G. Simchen, and N. Benvenisty Two Yeast Homologs of ECA39, a Target for c-Myc Regulation, Code for Cytosolic and Mitochondrial Branched-chain Amino Acid Aminotransferases J. Biol. Chem., August 23, 1996; 271(34): 20242 - 20245. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Bennett, G. I. Evan, and S. M. Schwartz Apoptosis of Rat Vascular Smooth Muscle Cells Is Regulated by p53-Dependent and -Independent Pathways Circ. Res., August 1, 1995; 77(2): 266 - 273. [Abstract] [Full Text] |
||||
![]() |
A J Wagner, J M Kokontis, and N Hay Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes & Dev., December 1, 1994; 8(23): 2817 - 2830. [Abstract] [PDF] |
||||
![]() |
S R Hann, M Dixit, R C Sears, and L Sealy The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. Genes & Dev., October 15, 1994; 8(20): 2441 - 2452. [Abstract] [PDF] |
||||
![]() |
P.J. Hurlin, D.E. Ayer, C. Grandori, and R.N. Eisenman The Max Transcription Factor Network: Involvement of Mad in Differentiation and an Approach to Identification of Target Genes Cold Spring Harb Symp Quant Biol, January 1, 1994; 59(0): 109 - 116. [Abstract] [PDF] |
||||
![]() |
D E Ayer and R N Eisenman A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes & Dev., November 1, 1993; 7(11): 2110 - 2119. [Abstract] [PDF] |
||||
![]() |
A. L. Gartel, X. Ye, E. Goufman, P. Shianov, N. Hay, F. Najmabadi, and A. L. Tyner Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3 PNAS, April 10, 2001; 98(8): 4510 - 4515. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |